Last edition
News about " GSK to Invest USD 30 Billion in US "
GSK to Invest USD 30 Billion in US R&D and Supply Chain Over Next 5 Years
GSK has announced plans to invest USD 30 billion across the United States over the next five years to strengthen its R&D, drug discovery, development, and clinical trial activity.
GSK To Invest USD 30 Billion In US | 17/09/2025 | By Dineshwori
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members